• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMC3232C150TE
Device Problems Leak/Splash (1354); Device Damaged by Another Device (2915)
Patient Problem Insufficient Information (4580)
Event Date 03/06/2024
Event Type  Injury  
Event Description
A valiant captivia stent graft was implanted in the endovascular treatment of a thoracic dissection and aneurysm.1 year and 5 months later a valiant navion ((b)(6)) stent graft was implanted to treat a type ia endoleak.The taa diameter was 68mm.During the intervention procedure, a carotid subclavian bypass on the left with 6 mm ring-reinforced ptfe prosthesis, followed by the implant of the valiant navion and plug closure of the subclavian artery from the brachial left was performed and a non mdt stent was placed at the outlet of the common carotid artery on the left, vascular suture of the brachial artery on the left.Per the physician the cause of the type ia endoleak was probably due to the very narrow landing zone distal to the left subclavian artery.Four years post the implant of the a valiant navion stent graft ,a follow up ct showed contrast medium exit from the navion graft m aterial, in the sense of a material defect (graft tear).Per the physician the cause of the suspected type iiib endoleak is possibly device related.It is suspected that the type iiib endoleak in the valiant navion stent graft may have been caused by the stent struts from the previously implanted valiant captivia.No additional clinical sequalae were provided and the patient will be monitored.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Manufacturer Narrative
B5; additional information received; corelab review of ct imaging from approximately 4 years since the navion implantation identified a type iiib endoleak and stent ring enlargement of +2.9mm on device vnmc3737c182te (v29789816).No fracture or stent ring migration were noted.Aortic enlargement of +5.4mm was observed when compared to previous imaging from 2 days after implantation.The maximum aortic diameter was noted to measure 78.9mm.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - CW
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18977161
MDR Text Key338553203
Report Number9612164-2024-01453
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/20/2020
Device Model NumberVAMC3232C150TE
Device Catalogue NumberVAMC3232C150TE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/15/2024
Initial Date FDA Received03/26/2024
Supplement Dates Manufacturer Received04/08/2024
Supplement Dates FDA Received04/12/2024
Date Device Manufactured02/20/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexFemale
-
-